De novo malignant melanoma occurred in renal allograft: DNA typing to determine the origin of the tumour

Abstract Malignant diseases are considered as great challenges in clinical transplantation. It is well known that the incidence of malignancy is higher in the transplanted population if compared with the normal population. It is important to distinguish between neoplastic diseases originating from pre-existing lesions in the transplanted organs and de novo graft tumours. Post-transplant malignancy of donor origin is a rare complication of organ transplantation, most likely transmitted as micrometastases within the parenchyma of the donor organ or from circulating tumour cells contained within the organ. Malignant melanoma, although its incidence is rather low, is one of the most common donor-derived tumour inadvertently transplanted, comprising 28% of donor transmitted tumours. Malignant melanoma in the graft without dermatological localisation is extremely rare. We report a case of de novo melanoma occurring in the allograft, where transmission from the donor was excluded by DNA (desoxyribonucleic acid) ...

[1]  H. Heynemann,et al.  Maligne Neoplasien und Nierentransplantation , 2009, Der Urologe.

[2]  I. Carmody,et al.  Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review , 2009, Clinical transplantation.

[3]  A. Webster,et al.  Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[4]  D. Hanto,et al.  Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. , 2007, Transplantation.

[5]  A. Crispin,et al.  The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. , 2007, Kidney international.

[6]  É. Toronyi,et al.  Malignancies after renal transplantation during 33 years at a single center , 2007, Pathology & Oncology Research.

[7]  F. Moloney,et al.  Malignant melanoma in transplant patients: review of five cases , 2006, Clinical and experimental dermatology.

[8]  G. Russ,et al.  The transmission of donor‐derived malignant melanoma to a renal allograft recipient , 2006, Clinical transplantation.

[9]  D. Hanto,et al.  Post‐transplant de novo malignancies in renal transplant recipients: the past and present , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  F. Wojnarowska,et al.  Melanomas in renal transplant recipients , 2006, The British journal of dermatology.

[11]  C. Hollenbeak,et al.  Increased incidence of melanoma in renal transplantation recipients , 2005, Cancer.

[12]  B. Kahan,et al.  Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies , 2005, Transplantation.

[13]  E. Morelon,et al.  Cancers et immunosuppression : effet pro- et antitumoral des traitements immunosuppresseurs , 2005 .

[14]  B. Kasiske,et al.  Cancer after Kidney Transplantation in the United States , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  M. Mason,et al.  Transmission of Donor Melanoma to Multiple Organ Transplant Recipients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  J. Járay,et al.  De novo tumors after kidney transplantation: the Budapest experience. , 2003, Transplantation proceedings.

[17]  A. Falus,et al.  DNA Typing Revealing High HLA-Cw Polymorphism Completes Availability of Major Histocompatibility Complex Loci in Forensic Medicine , 2003, The American journal of forensic medicine and pathology.

[18]  R. MacKie,et al.  Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. , 2003, The New England journal of medicine.

[19]  G. Everson,et al.  Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. , 2000, Transplantation.

[20]  P. Sótonyi,et al.  Papillary microcarcinoma of the thyroid gland in renal transplant patients , 2000, Pathology Oncology Research.

[21]  P. Sótonyi,et al.  Primary Hepatic Carcinoid in a Renal Transplant Patient , 1999, Pathology & Oncology Research.

[22]  P. Hogan,et al.  Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation. , 1998, Transplantation.

[23]  T. Kirchner,et al.  Highly sensitive DNA typing for detecting tumors transmitted by transplantation , 1998, Transplant international : official journal of the European Society for Organ Transplantation.

[24]  M. Barnardo,et al.  High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. , 1996, Tissue antigens.

[25]  C. Ponticelli,et al.  Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. , 1996, Clinical transplantation.

[26]  I. Penn.  Malignant melanoma in organ allograft recipients. , 1996, Transplantation.

[27]  I. Penn.  Primary kidney tumors before and after renal transplantation. , 1995, Transplantation.

[28]  J. Muñoz,et al.  [Malignant neoplasms and kidney transplantation]. , 1994, Actas urologicas espanolas.

[29]  R. Horvat,et al.  Identification of donor melanoma in a renal transplant recipient. , 1992, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[30]  O. Olerup,et al.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.

[31]  G. Bein,et al.  Rapid HLA-DRB1 genotyping by nested PCR amplification. , 1992, Tissue antigens.

[32]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[33]  E. Morelon,et al.  [Cancer and immunosuppression: pro- and antitumoral effects of immunosuppressive drugs]. , 2005, Nephrologie & therapeutique.

[34]  S. Sandrini,et al.  [Cancer after kidney transplantation]. , 2004, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

[35]  D. Stippel,et al.  Tumors after renal transplantation. , 1996, Urologia internationalis.

[36]  M. Barnardo,et al.  High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. , 1996, Tissue antigens.